Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypersensitivity to 5-ASA suppositories.

× No keyword cloud information.

42 in total

1. Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes.

Authors: A A Mihas; D J Goldenberg; R L Slaughter
Journal: JAMA Date: 1978-06-16 Impact factor: 56.272

2. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.

Authors: Y Niv
Journal: Isr J Med Sci Date: 1987-11

3. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

Authors: M Campieri; G A Lanfranchi; G Bazzocchi; C Brignola; F Sarti; G Franzin; A Battocchia; G Labo; P R Dal Monte
Journal: Lancet Date: 1981-08-08 Impact factor: 79.321

4. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

Authors: K M Das; M A Eastwood; J P McManus; W Sircus
Journal: N Engl J Med Date: 1973-09-06 Impact factor: 91.245

5. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors: D Rachmilewitz
Journal: BMJ Date: 1989-01-14

6. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

Authors: M Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Journal: Gut Date: 1985-04 Impact factor: 23.059

7. Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

Authors: J R Collins
Journal: South Med J Date: 1968-04 Impact factor: 0.954

8. Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.

Authors: R P Chan; D J Pope; A P Gilbert; P J Sacra; J H Baron; J E Lennard-Jones
Journal: Dig Dis Sci Date: 1983-07 Impact factor: 3.199

9. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides.

Authors: U Turunen; I Elomaa; V J Anttila; K Seppälä
Journal: Scand J Gastroenterol Date: 1987-09 Impact factor: 2.423

10. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.

Authors: S A Riley; V Mani; M J Goodman; M E Herd; S Dutt; L A Turnberg
Journal: Gut Date: 1988-05 Impact factor: 23.059

5 in total

Hypersensitivity to 5-ASA suppositories.

1. Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes.

2. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.

3. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.

4. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

5. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

6. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

7. Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

8. Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.

9. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides.

10. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.

1. Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

2. Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

3. Hypersensitivity to 5-ASA suppositories.

4. Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

5. Acute eosinophilic pneumonia related to a mesalazine suppository.